SEETA TRIVEDI
Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology EDISON, NJ NPI 1295962728
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology NJ Mirati Therapeutics, Inc. All categories
General Payments — all program years on this page
$6,166.66
- Category: General Payments
- Program years: PY2018–2024
- Record count: 89
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $135.78 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $118.76 | 6 |
| Education | $17.02 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Mirati Therapeutics, Inc. | $43.85 | 2 |
| Daiichi Sankyo Inc. | $24.99 | 1 |
| Merck Sharp & Dohme Corporation | $19.31 | 1 |
| Regeneron Healthcare Solutions, Inc. | $17.02 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $15.97 | 1 |
| Celgene Corporation | $14.64 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1089492426 | Daiichi Sankyo Inc. | $24.99 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101167920 | Celgene Corporation | $14.64 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1113845246 | PUMA BIOTECHNOLOGY, INC. | $15.97 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114224665 | Regeneron Healthcare Solutions, Inc. | $17.02 | 08/07/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1117174042 | Mirati Therapeutics, Inc. | $23.38 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117174046 | Mirati Therapeutics, Inc. | $20.47 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141574682 | Merck Sharp & Dohme LLC | $19.31 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.